https://www.marketscreener.com/quote/stock/WEREWOLF-THERAPEUTICS-INC-122186740/news/Werewolf-Therapeutics-Presents-Preliminary-Monotherapy-Data-from-Phase-1-1b-Clinical-Trial-Establish-45236997/?utm_source=telegram&utm_medium=social&utm_campaign=share